| One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy O Shuvalov, A Petukhov, A Daks, O Fedorova, E Vasileva, NA Barlev Oncotarget 8 (14), 23955, 2017 | 159 | 2017 |
| Specific drug delivery to cancer cells with double-imprinted nanoparticles against epidermal growth factor receptor F Canfarotta, L Lezina, A Guerreiro, J Czulak, A Petukhov, A Daks, ... Nano letters 18 (8), 4641-4646, 2018 | 154 | 2018 |
| Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer S Parfenyev, A Singh, O Fedorova, A Daks, R Kulshreshtha, NA Barlev Cell death & disease 12 (1), 17, 2021 | 63 | 2021 |
| Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis O Fedorova, A Petukhov, A Daks, O Shuvalov, T Leonova, E Vasileva, ... Oncogene 38 (12), 2108-2122, 2019 | 54 | 2019 |
| Linking metabolic reprogramming, plasticity and tumor progression O Shuvalov, A Daks, O Fedorova, A Petukhov, N Barlev Cancers 13 (4), 762, 2021 | 36 | 2021 |
| Attenuation of p53 mutant as an approach for treatment Her2-positive cancer O Fedorova, A Daks, O Shuvalov, A Kizenko, A Petukhov, Y Gnennaya, ... Cell death discovery 6 (1), 100, 2020 | 35 | 2020 |
| Current genome editing tools in gene therapy: new approaches to treat cancer O Shuvalov, A Petukhov, A Daks, O Fedorova, A Ermakov, G Melino, ... Current gene therapy 15 (5), 511-529, 2015 | 33 | 2015 |
| Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis O Fedorova, A Daks, V Petrova, A Petukhov, L Lezina, O Shuvalov, ... Cell Cycle 17 (15), 1917-1930, 2018 | 31 | 2018 |
| The Role of PTEN in Epithelial–Mesenchymal Transition O Fedorova, S Parfenyev, A Daks, O Shuvalov, NA Barlev Cancers 14 (15), 3786, 2022 | 28 | 2022 |
| Polymorphic heterochromatic segments in Japanese quail microchromosomes A Krasikova, A Daks, A Zlotina, E Gaginskaya Cytogenetic and genome research 126 (1-2), 148-155, 2009 | 28 | 2009 |
| An arthropod hormone, ecdysterone, inhibits the growth of breast cancer cells via different mechanisms O Shuvalov, O Fedorova, E Tananykina, Y Gnennaya, A Daks, ... Frontiers in Pharmacology 11, 561537, 2020 | 27 | 2020 |
| Effects of mycoplasma infection on the host organism response via p53/NF‐κB signaling SN Borchsenius, A Daks, O Fedorova, O Chernova, NA Barlev Journal of cellular physiology 234 (1), 171-180, 2019 | 26 | 2019 |
| E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells A Daks, A Petukhov, O Fedorova, O Shuvalov, V Merkulov, E Vasileva, ... Genes & cancer 7 (11-12), 383, 2016 | 26 | 2016 |
| Strategies to circumvent the side-effects of immunotherapy using allogeneic CAR-T cells and boost its efficacy: results of recent clinical trials S Smirnov, A Petukhov, K Levchuk, S Kulemzin, A Staliarova, K Lepik, ... Frontiers in Immunology 12, 780145, 2021 | 25 | 2021 |
| Set7/9 controls proliferation and genotoxic drug resistance of NSCLC cells A Daks, V Mamontova, O Fedorova, A Petukhov, O Shuvalov, S Parfenyev, ... Biochemical and Biophysical Research Communications 572, 41-48, 2021 | 24 | 2021 |
| The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase A Daks, A Petukhov, O Fedorova, O Shuvalov, A Kizenko, E Tananykina, ... Cell death & disease 12 (6), 581, 2021 | 22 | 2021 |
| KMT Set7/9 is a new regulator of Sam68 STAR-protein E Vasileva, O Shuvalov, A Petukhov, O Fedorova, A Daks, R Nader, ... Biochemical and biophysical research communications 525 (4), 1018-1024, 2020 | 22 | 2020 |
| Opposing roles of wild-type and mutant p53 in the process of epithelial to mesenchymal transition O Semenov, A Daks, O Fedorova, O Shuvalov, NA Barlev Frontiers in Molecular Biosciences 9, 928399, 2022 | 21 | 2022 |
| SEMG1/2 augment energy metabolism of tumor cells O Shuvalov, A Kizenko, A Petukhov, O Fedorova, A Daks, A Bottrill, ... Cell Death & Disease 11 (12), 1047, 2020 | 21 | 2020 |
| Ca2+‐depended signaling pathways regulate self‐renewal and pluripotency of stem cells A Ermakov, A Daks, O Fedorova, O Shuvalov, NA Barlev Cell Biology International 42 (9), 1086-1096, 2018 | 20 | 2018 |